Using a modified herpes virus to treat brain tumors in children
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
This study is testing a special virus treatment for kids aged 3-18 with tough brain tumors, hoping to see if it can help them live longer and feel better when combined with radiation therapy.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Treovir, INC NIH-funded |
| Lab location | 1 site (Birmingham, UNITED STATES) |
| Project ID | NIH-10244948 on NIH RePORTER |
What this research studies
This research investigates the use of a specially modified herpes simplex virus (G207) to treat children aged 3-18 who have recurrent or progressive high-grade gliomas, a type of brain tumor. The trial aims to assess the effectiveness and safety of this treatment, which has shown promising results in earlier studies. Participants will receive the virus through direct infusion into the tumor, potentially in combination with radiation therapy. The study builds on previous findings that suggest this approach may improve survival rates in affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 3-18 diagnosed with recurrent or progressive high-grade gliomas.
Not a fit: Patients with low-grade gliomas or those who are not experiencing tumor recurrence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for children suffering from aggressive brain tumors.
How similar studies have performed: Previous studies using similar approaches have shown promising results, indicating potential for success in this trial.
Where this research is happening
Birmingham, UNITED STATES
- Treovir, INC — Birmingham, United States (Active)
Researchers
- Principal investigator: Gillespie, George Yancey — Treovir, INC
- Study coordinator: Gillespie, George Yancey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.